Search research articles
Contact Us
Filters
Showing results (31-40 of 74) with videos related to
Page
of 8
Sort By:
Cancer Gene Therapy
|
February 25, 2006
Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD
M Majem, M Cascallo, N Bayo-Puxan, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
December 1, 1973
[Development of hydrochloric-peptic secretion in rats with subacute ulcer of the stomach and duodenum. New experimental model]
R Monfort Albelda, Y Sánchez de la Cuesta, J R Alemany Ontiveros, et al.
La Medicina Del Lavoro
|
February 1, 1971
Cardiac, enzymatic and arterial acid-base equilibrium alterations produced by electric current. An experimental study
J M Carrasco de Salas, R Monfort Albelda, R Hernandez Martinez, et al.
Cancer Gene Therapy
|
March 17, 1999
Complementary adenoviral vectors for oncolysis
R Alemany, S Lai, Y C Lou, et al.
Journal of Cell Science
|
April 1, 1993
Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells
R Alemany, M R Vilá, C Francí, et al.
Gynecologic Oncology
|
March 1, 1996
Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro
K Hamada, W W Zhang, R Alemany, et al.
British Journal of Pharmacology
|
August 1, 1996
Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites
P V Escribá, R Alemany, M Sastre, et al.
European Journal of Pharmacology
|
July 4, 1995
LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration
R Alemany, G Olmos, P V Escribá, et al.
Gene Therapy
|
August 24, 2007
GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model
A Cascante, D Abate-Daga, L Garcia-Rodríguez, et al.
Gene Therapy
|
August 28, 2009
A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
J J Rojas, M Cascallo, S Guedan, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 74) with videos related to
Sort By:
Page
of 8
Cancer Gene Therapy
|
February 25, 2006
Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD
M Majem, M Cascallo, N Bayo-Puxan, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo
|
December 1, 1973
[Development of hydrochloric-peptic secretion in rats with subacute ulcer of the stomach and duodenum. New experimental model]
R Monfort Albelda, Y Sánchez de la Cuesta, J R Alemany Ontiveros, et al.
La Medicina Del Lavoro
|
February 1, 1971
Cardiac, enzymatic and arterial acid-base equilibrium alterations produced by electric current. An experimental study
J M Carrasco de Salas, R Monfort Albelda, R Hernandez Martinez, et al.
Cancer Gene Therapy
|
March 17, 1999
Complementary adenoviral vectors for oncolysis
R Alemany, S Lai, Y C Lou, et al.
Journal of Cell Science
|
April 1, 1993
Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells
R Alemany, M R Vilá, C Francí, et al.
Gynecologic Oncology
|
March 1, 1996
Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro
K Hamada, W W Zhang, R Alemany, et al.
British Journal of Pharmacology
|
August 1, 1996
Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites
P V Escribá, R Alemany, M Sastre, et al.
European Journal of Pharmacology
|
July 4, 1995
LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration
R Alemany, G Olmos, P V Escribá, et al.
Gene Therapy
|
August 24, 2007
GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model
A Cascante, D Abate-Daga, L Garcia-Rodríguez, et al.
Gene Therapy
|
August 28, 2009
A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
J J Rojas, M Cascallo, S Guedan, et al.
Page
of 8